BCL2 and breast cancer: For instance, in breast cancer cells, activated Raf conferred resistance to the chemotherapeutic drugs doxorubicin and paclitaxel by inducing the expression of the drug pump Mdr-1 and the Bcl-2 antiapoptotic protein [15].